U.S. Court of Appeals for the Federal Circuit
Allergan Sales, LLC v. Sandoz, Inc.
This writing
- Type
- Concurrence
- Filed
- Aug. 29, 2019
- Case
- Allergan Sales, LLC v. Sandoz, Inc.
- Case status
- Decided
Source No authoring judge could be established for this writing, either from provider metadata or from the signature line of the court's published opinion. Benchlight shows the gap rather than guessing at an author.
Opening text
The first passage of the document, as extracted by the source provider.
Prost, Chief Judge, concurring. The central question before us is whether the "wherein" clauses here are limiting. Claim 1 of the '453 patent expressly recites two "wherein" clauses, which set out specific safety and efficacy benchmarks for the claimed formulation. However, Sandoz invites us to read these requirements out of the claim. Sandoz insists that these "wherein" clauses are mere statements of inherent results or genera…
Source Extract supplied by CourtListener. Benchlight does not host the document — read the authoritative text in the court's own PDF.
Other writings in this case
| Type | Author | Filed |
|---|---|---|
| Opinion | Not attributed | Aug. 29, 2019 |
| Opinion of the Court | Not attributed | Aug. 29, 2019 |